Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study

Objectives. To evaluate oral tofacitinib versus placebo for treatment of active rheumatoid arthritis in Japanese patients with inadequate response to disease-modifying antirheumatic drugs. Methods. In this double-blind, placebo-controlled, randomized, parallel-group, 12-week, phase 2 study (clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yoshiya, Takeuchi, Tsutomu, Yamanaka, Hisashi, Nakamura, Hiroyuki, Toyoizumi, Shigeyuki, Zwillich, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819568/
https://www.ncbi.nlm.nih.gov/pubmed/25496464
http://dx.doi.org/10.3109/14397595.2014.995875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819568/
https://www.ncbi.nlm.nih.gov/pubmed/25496464
http://dx.doi.org/10.3109/14397595.2014.995875

Ejemplares similares